Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 clinical trial of a monoclonal antibody therapy in patients with metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED